Status:
COMPLETED
A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy
Lead Sponsor:
The University of Hong Kong
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the sensitivity and specificity of the combination of EBV and methylation marker genes in body fluids of both plasma and nasopharyngeal brush together for screening of early salvageable lo...
Detailed Description
1\. Background: Treatment failure can occur at distant sites which have no effective cure yet. Early local residual or recurrent NPC are salvageable with over 50% 5-year survival rate. It is however d...
Eligibility Criteria
Inclusion
- diagnosed with nasopharngeal carcinoma
- will receive radiotherapy after basline NP brush
Exclusion
- has received radiotherapy
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
426 Patients enrolled
Trial Details
Trial ID
NCT03379610
Start Date
January 1 2006
End Date
December 1 2018
Last Update
April 30 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.